Literature DB >> 2499978

Neural crest origin of clear cell sarcoma of tendons and aponeuroses. Ultrastructural and enzyme cytochemical study of human and nude mouse-transplanted tumours.

Y Mii1, Y Miyauchi, K Hohnoki, H Maruyama, M Tsutsumi, K Dohmae, S Tamai, Y Konishi, T Yamanouchi.   

Abstract

In order to clarify the histogenesis of clear cell sarcoma of tendons and aponeuroses (CCS), two cases of human and one nude mouse-transplanted CCS line were studied using an ultrastructural and enzyme cytochemical approach. Most of the tumour cells obtained from the primary and transplanted CCS demonstrated melanosomes in various stages of development within the cytoplasm, whereas no melanosomes could be identified in the metastatic CCS. However, cholinesterase and tyrosinase activities could be demonstrated not only in the melanotic primary and transplanted CCS but also in the amelanotic metastatic CCS. The results therefore support the hypothesis that CCS is a soft tissue tumour derived from the neural crest.

Entities:  

Mesh:

Year:  1989        PMID: 2499978     DOI: 10.1007/bf00718604

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  37 in total

1.  A STUDY OF THE HISTOGENESIS OF EXPERIMENTAL MELANOTIC TUMORS RESEMBLING CELLULAR BLUE NEVI: THE EVIDENCE IN SUPPORT OF THEIR NEUROGENIC ORIGIN.

Authors:  T NAKAI; H RAPPAPORT
Journal:  Am J Pathol       Date:  1963-08       Impact factor: 4.307

2.  Clear-cell sarcoma of patellar tendon studied by electron microscopy.

Authors:  T Kubo
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

3.  Clear cell sarcoma. A clinicopathologic study of 27 cases.

Authors:  J J Eckardt; D J Pritchard; E H Soule
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

4.  Clear-cell sarcoma with melanin pigment: a possible soft-tissue variant of malignant melanoma. Case report.

Authors:  A C Raynor; F Vargas-Cortes; R W Alexander; H G Bingham
Journal:  J Bone Joint Surg Am       Date:  1979-03       Impact factor: 5.284

5.  Melanogenesis: ultrastructural histochemical observations on ultraviolet irradiated human melanocytes.

Authors:  J A Hunter; J H Mottaz; A S Zelickson
Journal:  J Invest Dermatol       Date:  1970-03       Impact factor: 8.551

6.  Malignant melanoma of soft parts: an ultrastructural study of four cases.

Authors:  J D Benson; B B Kraemer; B Mackay
Journal:  Ultrastruct Pathol       Date:  1985       Impact factor: 1.094

7.  Clear-cell sarcoma of tendons and aponeuroses. An immunohistochemical and electron microscopic analysis indicating neural crest origin.

Authors:  L G Kindblom; P Lodding; L Angervall
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

8.  Use of a newly established human cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma.

Authors:  A L Epstein; A O Martin; R Kempson
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

9.  Human malignant melanoma. Melanosomal polymorphism and the ultrastructural dopa reaction.

Authors:  J A Hunter; W D Paterson; D J Fairley
Journal:  Br J Dermatol       Date:  1978-04       Impact factor: 9.302

10.  THE LOCALIZATION OF CHOLINESTERASE ACTIVITY IN RAT CARDIAC MUSCLE BY ELECTRON MICROSCOPY.

Authors:  M J KARNOVSKY
Journal:  J Cell Biol       Date:  1964-11       Impact factor: 10.539

View more
  3 in total

1.  Establishment and characterization of a clear-cell sarcoma (malignant melanoma of soft parts) cell line.

Authors:  T Takenouchi; K Ito; T Kazama; M Ito
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

2.  Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2.

Authors:  Manuel Pedro Jimenez-García; Antonio Lucena-Cacace; Daniel Otero-Albiol; Amancio Carnero
Journal:  Cell Death Dis       Date:  2021-05-20       Impact factor: 8.469

3.  CD151 confers metastatic potential to clear cell sarcoma of the soft tissue in animal model.

Authors:  Keisuke Kawashima; Chiemi Saigo; Yusuke Kito; Yuki Hanamatsu; Yuki Egawa; Tamotsu Takeuchi
Journal:  Oncol Lett       Date:  2019-03-19       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.